Healthcare Services

Generative AI in Healthcare Market: Growth Drivers and Outlook

April 21, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Much Will The Market Value Of The Generative AI In Healthcare Market Grow Between 2026 And 2030?

The generative ai in healthcare market has experienced substantial growth in its size over recent years. This market is anticipated to expand from $3.23 billion in 2025 to reach $4.44 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 37.2%. Historically, this growth can be ascribed to several factors, including the digitization of healthcare data, progress in machine learning algorithms, the proliferation of electronic health records, increased investment in healthcare IT, and the pressing demand for efficiency.

The generative ai in healthcare market size is anticipated to experience substantial growth in the coming years, with projections indicating it will reach $13.11 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 31.1%. This expansion during the forecast period is fueled by several factors, including regulatory acceptance of AI tools, increased adoption of AI in clinical practices, broader utilization of real-world data, advancements in hospital automation, and the emergence of AI-driven personalized care. Furthermore, significant trends identified for this period encompass the growing implementation of AI-assisted clinical decision support, the wider application of AI in medical imaging analysis, the increasing integration of virtual nursing assistants, the embedding of AI into workflow automation, and the rising deployment of predictive healthcare analytics.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/generative-ai-in-healthcare-global-market-report

Which Key Factors Are Driving The Generative AI In Healthcare Market Growth?

The escalating need for personalized medicine is anticipated to stimulate the growth of the generative AI in healthcare market moving forward. Personalized medicine, also referred to as precision medicine, represents a groundbreaking strategy in medical treatment that factors in each individual’s unique variations in genes, environment, and lifestyle. This increasing demand for personalized medicine stems from several elements, including breakthroughs in genomics, a deeper comprehension of disease mechanisms, and the pursuit of more efficacious and precise treatments. Generative AI in healthcare employs algorithms to scrutinize extensive patient data, such as genetic profiles and medical histories, to develop customized treatment plans and forecasts aligned with individual patient needs and characteristics. For example, in February 2024, as reported by the Personalized Medicine Coalition, a UK-based entity advocating for the adoption of personalized medicine, the FDA’s CDER approved 16 new personalized treatments for rare disease patients in 2023, an increase from 6 in 2022. These sanctioned personalized treatments encompassed seven medications specifically for cancer therapy and three formulated for addressing a range of other diseases and conditions. Consequently, the rising demand for personalized medicine is a significant driver of the generative AI in healthcare market’s expansion.

What Are The Main Segments Within The Generative AI In Healthcare Market Segment Structure?

The generative ai in healthcare market covered in this report is segmented –

1) By Component: Solutions, Services

2) By Function: AI-Assisted Robotic Surgery, Virtual Nursing Assistants, Aid Clinical Judgment Or Diagnosis, Workflow And Administrative Tasks, Image Analysis

3) By Application: Clinical, System

4) By End User: Hospitals And Clinics, Clinical Research, Healthcare Organizations, Diagnostic Centers, Other End Users

Subsegments:

1) By Solutions: Diagnostic Imaging Analysis, Drug Discovery And Development Tools, Personalized Treatment Planning, AI-Powered Clinical Decision Support

2) By Services: Consulting and Advisory Services, Implementation And Integration Services, Support And Maintenance Services, Training And Education Services

Which Trends Are Guiding The Direction Of The Generative AI In Healthcare Market?

Key players operating in the generative AI in healthcare market are prioritizing the establishment of strategic collaborations to innovate new technologies and gain a competitive edge. These alliances are essential for advancing generative AI in the healthcare sector, as they pool the strengths and resources of various organizations to develop cutting-edge solutions, enhance the efficiency of clinical processes, and tackle significant healthcare challenges. For example, in June 2023, Google, a technology company from the US, joined forces with Mayo Clinic, a US-based nonprofit organization focused on clinical practices, to integrate generative AI into healthcare. This collaboration seeks to utilize generative AI’s potential to streamline operations and improve healthcare service delivery by making previously inaccessible information available and enabling real-time, customized interactions. The initial phase will concentrate on Enterprise Search within Gen App Builder to enhance clinical workflows and patient outcomes while maintaining adherence to HIPAA (Health Insurance Portability and Accountability Act) regulations.

Who Are The Companies Participating In The Generative AI In Healthcare Market?

Major companies operating in the generative ai in healthcare market are Alphabet Inc., Microsoft Corporation, Amazon Web Services Inc., Johnson & Johnson Services Inc., Siemens AG, Intel Corporation, IBM Watson Health Corporation, Oracle Corporation, Nvidia Corporation, Epic Systems Corporation, Persistent Systems Private Limited, Tempus Labs Inc., Eleks Inc., Verge Genomics Inc., PathAI Inc., BenevolentAI Ltd, Abridge AI Inc., Absci Corporation, Atomwise Inc., Syntegra, Insilico Medicine, DiagnaMed Holdings Corp.

Get The Full Generative AI In Healthcare Market Report:

https://www.thebusinessresearchcompany.com/report/generative-ai-in-healthcare-global-market-report

Which Region Accounts For The Largest Portion Of The Generative AI In Healthcare Market?

North America was the largest region in the generative AI In healthcare market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the generative ai in healthcare market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Generative AI In Healthcare Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/generative-ai-in-healthcare-global-market-report

Browse Through More Reports Similar to the Global Generative AI In Healthcare Market 2026, By The Business Research Company

Ai In Medical Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/ai-in-medical-devices-global-market-report

Generative Ai Market Report 2026

https://www.thebusinessresearchcompany.com/report/generative-ai-global-market-report

Artificial Intelligence In Healthcare Market 2026

https://www.thebusinessresearchcompany.com/report/artificial-intelligence-in-healthcare-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795